DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

H.C. Wainwright Reiterates Buy on vTv Therapeutics, Raises Price Target to $6

H.C. Wainwright analyst Vernon Bernardino reiterates vTv Therapeutics (NASDAQ:VTVT) with a Buy and raises the price target from $5 to $6.

Benzinga · 02/10/2020 17:37

H.C. Wainwright analyst Vernon Bernardino reiterates vTv Therapeutics (NASDAQ:VTVT) with a Buy and raises the price target from $5 to $6.